Theralase PDT Technology Used to Treat Third Patient for Bladder Cancer
Theralase PDT Technology Used to Treat Second Patient for Bladder Cancer
A comprehensive update from Theralase
Theralase PDT Technology Used to Treat First Patient for Bladder Cancer
The stronger fundamental case this year for gold
An up date on Theralase now beginning the phase 1b clinical trial
Theralase AGM Presentation Video
Hour 1 – Coverage on Gold, Uranium and Theralase
PART TWO OF OUR DISCUSSION WITH DR. MICHAEL JEWETT, WHO IS THE CHAIRMAN OF THE PHOTODYNAMIC THERAPY MEDICAL AND SCIENTIFIC ADVISORY BOARD OF THERALASE
Part One of our discussion with Dr. Michael Jewett, who is the Chairman of the Photodynamic Therapy Medical and Scientific Advisory Board of Theralase
Theralase Increases GBM Brain Cancer Survival by 925%
Health Canada Grants Theralase ITA Approval
Full interview with Roger White from Theralase
DID THIS DROP IN GOLD RESULT IN A BUYING OPPORTUNITY?
Theralase Provides Update on ITA Application to Health Canada
Theralase Increases Revenue 32% in 2H2016 Financials
2016 Sprott Natural Resource Symposium
Theralase Files ITA Application to Health Canada
Clinical and Scientific Research Reports for Theralase
Theralase Increases Revenue 11% in Q12016 Financials

Fatal error: Call to undefined function http_response_code() in /home/kerepo5/public_html/wp-content/plugins/wp-cerber/cerber-load.php on line 5175